Every record from Janoshik · page 47
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018867 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.35 | 4.22 | 95.4 | Supplier-supplied | 0 | PASS |
| AX-2025-018862 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.63 | 4.07 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020641 | MOTS-c | SSA | SSA-2503-S7755 | 2025-Q3 | 99.36 | 5.36 | 104.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-020330 | Tirzepatide | MKM | MKM-2411-B2994 | 2025-Q2 | 98.40 | 4.39 | 106.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019668 | Semaglutide | Homopeptide | HOMO-2505-X2210 | 2025-Q3 | 99.11 | 2.61 | 101.4 | Supplier-supplied | 3 | FAIL |
| AX-2025-018935 | Exenatide | FGP | FGP-2504-V9993 | 2025-Q2 | 99.27 | 4.09 | 97.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021243 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.38 | 6.17 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-019805 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 98.87 | 4.41 | 89.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019186 | Tirzepatide | TFC | TFC-2507-T5380 | 2025-Q3 | 97.99 | 3.89 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018902 | GHRP-6 | FGP | FGP-2411-J1249 | 2025-Q2 | 99.93 | 5.85 | 101.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018408 | Dihexa | WWB | WWB-2507-N1598 | 2025-Q3 | 99.93 | 9.02 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-021316 | GHRP-2 | BCH | BCH-2506-L7534 | 2025-Q3 | 98.38 | 7.86 | 90.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-020947 | KPV | CPC | CPC-2502-M3212 | 2025-Q3 | 98.32 | 3.08 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020322 | Survodutide | MKM | MKM-2411-E3058 | 2025-Q2 | 98.62 | 4.87 | 91.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019727 | PEG-MGF | HJ | HJ-2507-S2872 | 2025-Q3 | 98.26 | 6.62 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019070 | Liraglutide | JEEP | JEEP-2411-B3841 | 2025-Q2 | 99.83 | 5.22 | 93.7 | Supplier-supplied | 0 | PASS |
| AX-2025-019425 | Semaglutide | Homopeptide | HOMO-2505-V8950 | 2025-Q3 | 98.50 | 6.24 | 101.9 | Supplier-supplied | 2 | FAIL |
| AX-2025-020373 | Retatrutide | MKM | MKM-2504-F3495 | 2025-Q2 | 98.59 | 7.12 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020190 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.93 | 4.50 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020704 | GHK-Cu | GL Biochem | GLBI-2502-L8987 | 2025-Q3 | 97.36 | 4.00 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020590 | Retatrutide | SSA | SSA-2508-N7223 | 2025-Q3 | 97.73 | 4.88 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020565 | Vilon | SSA | SSA-2508-B6325 | 2025-Q3 | 99.15 | 5.46 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-019749 | Semaglutide | HJ | HJ-2507-Y3362 | 2025-Q3 | 98.17 | 3.27 | 104.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019738 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.75 | 6.24 | 103.7 | Supplier-supplied | 0 | PASS |
| AX-2025-020676 | MK-677 (Ibutamoren mesylate) | GL Biochem | GLBI-2501-Y8359 | 2025-Q2 | 98.48 | 4.62 | 90.6 | Supplier-supplied | 3 | FAIL |
| AX-2025-019158 | CJC-1295 (no DAC) | TFC | TFC-2411-M5192 | 2025-Q2 | 98.72 | 1.94 | 93.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018971 | KPV | FGP | FGP-2501-A1918 | 2025-Q2 | 99.93 | 3.05 | 89.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019471 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 99.17 | 6.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019117 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.93 | 5.44 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020720 | BPC-157 | GL Biochem | GLBI-2411-N8871 | 2025-Q2 | 99.43 | 7.02 | 98.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020646 | Semaglutide | SSA | SSA-2412-Y7639 | 2025-Q2 | 97.56 | 4.08 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018684 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 7.93 | 91.4 | Supplier-supplied | 0 | PASS |
| AX-2025-019346 | Retatrutide | TFC | TFC-2503-X7298 | 2025-Q3 | 99.40 | 6.84 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019085 | Tirzepatide | JEEP | JEEP-2412-U3223 | 2025-Q2 | 98.94 | 3.32 | 90.1 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020679 | MK-677 (Ibutamoren mesylate) | GL Biochem | GLBI-2501-Y8359 | 2025-Q2 | 98.52 | 4.88 | 106.1 | Supplier-supplied | 3 | FAIL |
| AX-2025-020613 | GHRP-2 | SSA | SSA-2505-D7439 | 2025-Q2 | 99.30 | 5.05 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021189 | PT-141 (Bremelanotide) | BCH | BCH-2502-H6657 | 2025-Q2 | 99.42 | 6.36 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020400 | TB-500 | KP | KP-2412-H4631 | 2025-Q2 | 98.63 | 4.35 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019472 | PEG-MGF | Homopeptide | HOMO-2412-B9129 | 2025-Q2 | 98.62 | 5.62 | 101.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018788 | TB-500 | QSC | QSC-2504-T7980 | 2025-Q2 | 99.42 | 3.52 | 99.2 | Supplier-supplied | 1 | MARGINAL |